HEM Pharma Inc. (376270.KQ)
KOSDAQ · KRW · Healthcare · Biotechnology
₩28,250 (+1.25%) as of
Key statistics
- Market cap
- 202.73B
- Dividend yield
- 0.00%
- 52-week range
- 26,100.00 – 97,500.00
- Revenue (TTM)
- 16.14B
- Profit margin
- -129.30%
- Volume
- 6.43k
About HEM Pharma Inc.
HEM Pharma Inc. operates as a microbiome healthcare company in South Korea and internationally. The company offers health functional food products, such as Nutrilite and my LAB microbiome solution. It also engages in the personalized analysis service and CDMO businesses. The company was founded in 2016 and is based in Pohang, South Korea.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Pohang, South Korea
- Employees
- 59
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.